DV
Dividend Vision

IMNM — Immunome, Inc.

Immunome, Inc. (IMNM)

Total return is 102.2% over the past 5.9 years, 49.3 points behind SPY at 151.5%. Its deepest 1-year drawdown was 33.6%.

IMNM is an equity fund focused on a single stock holding with an inception date of October 2020. The fund does not currently distribute dividends to shareholders and carries no published expense ratio or disclosed asset under management figures. This fund structure appeals primarily to investors seeking direct exposure to the underlying company's equity performance rather than income generation.

IMNM key facts

Asset type
Stock
Asset class
Equity
Inception date
10/02/2020
Distribution frequency
None
Last close
$27.20
Market cap
$3,089,311,744
Average volume
759900.0
Beta
2.117
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.53